Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Pohl and his destiny

Pohl and his destiny

posted on May 11, 2007 09:49AM

Pohl repeats often his intent of getting us off of BB and on to either AMEX or NASDAQ.  Assuming he is able to achieve that goal.  You think the flight we had to $2 will seem like a practice flight?  Correct me if I am wrong, but if we get off BB, aren’t the mutual funds able to purchase PTSC stock?  And what mutual fund won’t want a company that is paying semi-annual dividends, with no debt, and a long list of past infringement upon which to collect.  The mutual fund interest should propel PTSC to new levels.  Isn’t that what we all really need, is more buyers.  And the largest group of buying power will be the mutual funds.  It has to be what Swartz wants.  We share that goal with Swartz. 

Share
New Message
Please login to post a reply